{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:37:05Z","timestamp":1793371025562,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100023544","name":"National Taiwan University Hospital Hsin-Chu Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaad.2026.09.082","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:01:11Z","timestamp":1790319671000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and risk factors for a distinct pustular psoriasis flare after withdrawal of biologics in plaque psoriasis"],"prefix":"10.1016","author":[{"given":"Hsien-Yi","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Jen","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Huei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.09.082_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2026.09.082_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/ds.DS-D-23-00247","article-title":"Effectiveness of biologic treatment for psoriasis in Malaysia: Real-world evidence and review of current evidence from Southeast Asia","volume":"42","author":"Kwan","year":"2024","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.jaad.2026.09.082_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2133.2010.10139.x","article-title":"Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy","volume":"164","author":"Papp","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jaad.2023.01.029","article-title":"Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study","volume":"88","author":"Nielsen","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s40257-024-00887-8","article-title":"Predicting the time to relapse following withdrawal from different biologics in patients with psoriasis who responded to therapy: a 12-year multicenter cohort study","volume":"25","author":"Huang","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaad.2019.01.035","article-title":"Predictors of time to relapse following ustekinumab withdrawal in patients with psoriasis who had responded to therapy: an 8-year multicenter study","volume":"88","author":"Chiu","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/jocd.15638","article-title":"Clinical course of psoriasis patients that discontinued biologics during the COVID-19 pandemic","volume":"22","author":"Topaloglu Demir","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib8","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1111\/jdv.20841","article-title":"Withdrawal of biologic agents before pregnancy is associated with psoriasis flare","volume":"40","author":"Burle","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.09.082_bib9","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.jaad.2005.10.029","article-title":"Relapse, rebound, and psoriasis adverse events: an advisory group report","volume":"54","author":"Carey","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/bjd.14627","article-title":"Rebound pustular psoriasis after brodalumab discontinuation","volume":"175","author":"Khemis","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib11","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jdv.14387","article-title":"Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients","volume":"31","author":"Masson Regnault","year":"2017","journal-title":"J Eur Acad. Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.09.082_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jdcr.2017.06.026","article-title":"Erythrodermic psoriasis after discontinuation of ixekizumab","volume":"4","author":"Potter","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2026.09.082_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100116","article-title":"The relapse of psoriasis: mechanisms and mysteries","volume":"2","author":"Tian","year":"2022","journal-title":"JID Innov"},{"key":"10.1016\/j.jaad.2026.09.082_bib14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2023.11.017","article-title":"Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: appearances can be deceptive","volume":"153","author":"Migayron","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2026.09.082_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41584-024-01107-7","article-title":"Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis","volume":"20","author":"Chang","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s10067-024-06928-1","article-title":"Anti-tumor necrosis factor (aTNF) weaning strategy in juvenile idiopathic arthritis (JIA): does duration matter?","volume":"43","author":"Teh","year":"2024","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3899\/jrheum.2025-0390.PV183","article-title":"Belimumab reduces the risk of flares associated with the BAFF overexpressing TNFSF13B gene variant: a hint for personalized treatment in SLE","volume":"52","author":"Pireddu","year":"2025","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib18","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1007\/s12325-021-01698-7","article-title":"Clinical burden of concomitant joint disease in psoriasis: a US-linked claims and electronic health records database analysis","volume":"38","author":"Skornicki","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaad.2026.09.082_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40744-023-00635-0","article-title":"The impact of systemic lupus erythematosus flares on clinical and economic outcomes: the CHAMOMILE claims database study in Germany","volume":"11","author":"Ding","year":"2024","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jaad.2026.09.082_bib20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3899\/jrheum.170366","article-title":"Flares in patients with rheumatoid arthritis after total hip and total knee arthroplasty: rates, characteristics, and risk factors","volume":"45","author":"Goodman","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2026.09.082_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1396-0296.2004.04042.x","article-title":"Efalizumab in the treatment of psoriasis","volume":"17","author":"Leonardi","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.09.082_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000542344","article-title":"Time to loss of disease control following guselkumab withdrawal in relation to initial speed of response: a post hoc analysis of the VOYAGE 2 trial","volume":"241","author":"Kirby","year":"2024","journal-title":"Dermatology"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226036303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226036303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:28:14Z","timestamp":1793370494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226036303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"alternative-id":["S0190962226036303"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.09.082","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and risk factors for a distinct pustular psoriasis flare after withdrawal of biologics in plaque psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.09.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}